37 | Antiviral Agents (Antivirals)IBA
03/2024
-
08/2010 |
20 | InterferonsIBA
02/2020
-
03/2008 |
11 | Monoclonal AntibodiesIBA
12/2023
-
01/2019 |
11 | Anti-Bacterial Agents (Antibiotics)IBA
06/2023
-
03/2015 |
11 | Ribavirin (Virazole)FDA LinkGeneric
06/2020
-
05/2005 |
8 | SteroidsIBA
12/2023
-
03/2010 |
7 | Biomarkers (Surrogate Marker)IBA
11/2023
-
05/2010 |
7 | AntibodiesIBA
12/2020
-
05/2005 |
5 | AntigensIBA
07/2022
-
01/2018 |
5 | Alemtuzumab (Campath)FDA Link
10/2021
-
01/2018 |
5 | Protease Inhibitors (Protease Inhibitor)IBA
01/2021
-
01/2014 |
4 | Carbapenems (Carbapenem Antibiotics)IBA
09/2023
-
08/2020 |
4 | C-Reactive ProteinIBA
01/2023
-
10/2020 |
4 | Proteins (Proteins, Gene)FDA Link
02/2022
-
02/2020 |
4 | N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
02/2020
-
01/2014 |
3 | dalbavancinIBA
01/2024
-
10/2020 |
3 | remdesivirIBA
12/2023
-
01/2023 |
3 | Oxygen (Dioxygen)IBA
12/2023
-
11/2020 |
3 | Ritonavir (Norvir)FDA Link
12/2023
-
06/2020 |
3 | Prednisone (Sone)FDA LinkGeneric
01/2023
-
05/2005 |
3 | SofosbuvirIBA
11/2022
-
01/2014 |
3 | CytokinesIBA
07/2022
-
11/2020 |
3 | Interleukin-6 (Interleukin 6)IBA
07/2022
-
11/2020 |
3 | InterleukinsIBA
07/2022
-
01/2021 |
3 | Prothrombin (Factor II)IBA
01/2022
-
01/2013 |
3 | asunaprevirIBA
02/2020
-
01/2014 |
3 | Vitamin DFDA LinkGeneric
01/2019
-
05/2015 |
3 | Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2018
-
01/2013 |
3 | VaccinesIBA
01/2018
-
09/2012 |
3 | telaprevirIBA
01/2016
-
01/2014 |
2 | nirmatrelvir and ritonavir drug combinationIBA
12/2023
-
10/2022 |
2 | sotrovimabIBA
12/2023
-
01/2022 |
2 | Complement System Proteins (Complement)IBA
11/2023
-
01/2022 |
2 | CefiderocolIBA
09/2023
-
12/2022 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
08/2023
-
10/2021 |
2 | CreatinineIBA
07/2023
-
02/2020 |
2 | FluoroquinolonesIBA
05/2023
-
08/2020 |
2 | casirivimab and imdevimab drug combinationIBA
04/2023
-
02/2023 |
2 | glecaprevir and pibrentasvirIBA
11/2022
-
10/2019 |
2 | Troponin IIBA
09/2022
-
06/2021 |
2 | Interleukin-10 (Interleukin 10)IBA
07/2022
-
01/2022 |
2 | Interleukin-17 (Interleukin 17)IBA
07/2022
-
01/2021 |
2 | BilirubinIBA
06/2022
-
05/2005 |
2 | VancomycinFDA LinkGeneric
01/2022
-
08/2021 |
2 | AerosolsIBA
01/2022
-
01/2021 |
2 | pro-brain natriuretic peptide (1-76)IBA
06/2021
-
11/2020 |
2 | Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021
-
06/2020 |
2 | LopinavirFDA Link
01/2021
-
06/2020 |
2 | Oncogene Proteins (Oncogene Protein)IBA
01/2021
-
07/2020 |
2 | Immunoglobulin G (IgG)IBA
12/2020
-
05/2005 |
2 | tazobactam drug combination ceftolozaneIBA
03/2020
-
01/2017 |
2 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2020
-
01/2009 |
2 | 8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
02/2020
-
01/2015 |
2 | Alanine Transaminase (SGPT)IBA
02/2020
-
01/2009 |
2 | daclatasvirIBA
02/2020
-
10/2015 |